Disclosed herein are methods of treating a pulmonary bacterial infection comprising bacteria growing under anaerobic conditions using a fluoroquinolone antibiotic. The fluoroquinolone antibiotic may for example be levofloxacin or ofloxacin. Also disclosed are methods of inhibiting bacteria growing under anaerobic conditions by exposing the bacteria to an amount of fluoroquinolone antibiotic effective to inhibit growth of said bacteria.

FIELD: medicine.SUBSTANCE: invention refers to medicine and biotechnology and concerns treating an antibacterial agent for treating gastrointestinal diseases preferentially acute intestinal infections including unexplained. The declared preparation represents a mixture of an antibiotic and probiotic wherein the antibiotic is presented by ofloxacin while the probiotic is a bifidus bacterial biomass in the following ratio mg/capsule: ofloxacin - 200 mg bifidus bacterial biomass - 200 mg containing...

The present invention relates to methods and compositions for the treatment of pulmonary inflammation. In particular methods and compositions using aerosol levofloxacin or ofloxacin to reduce pulmonary inflammation are provided.

The present invention provides a one-step synthesizing method of levofloxacin and ofloxacin. S-910-difluoro-23-dihydro-3-methyl-7-oxygen-7H-pyrido[123-Delta]-[14]-benzoxazine-6-carboxylic acid ester or 910-difluoro-23-dihydro-3-methyl-7-oxygen-7H-pyrido[123-Delta]-[14]-benzoxazine-6-carboxylic acid ester is adopted as a raw material to react with alkali in an organic solvent or water or a mixed solvent of an organic solvent and water to obtain a corresponding carboxylic acid salt; the solvent is...

FIELD: medicine pharmaceutics.SUBSTANCE: invention refers to an antibacterial preparation for treating gastrointestinal diseases preferentially acute intestinal infections including unexplained. The declared preparation represents a mixture of an antibiotic and a biological ingredient wherein the antibiotic is presented by ofloxacin while the biological ingredient is a complex of immunoglobulins IgG(56-60):IgA(16-22):IgM(22-24) in the following ratio mg/flask: ofloxacin - 250 the complex of immu...